fura-2 has been researched along with manoalide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celardo, A; Cerletti, C; Evangelista, V; Rotondo, S | 1 |
| Maeda, H; Nakatani, Y; Nishimura, Y; Nishiuma, T; Yokoyama, M | 1 |
2 other study(ies) available for fura-2 and manoalide
| Article | Year |
|---|---|
The endoperoxides/TxA2 analogue, U46619, inhibits human polymorphonuclear leukocyte function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Calcimycin; Cell Adhesion; Fura-2; Humans; Indoles; Leukotriene Antagonists; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Prostaglandin Endoperoxides, Synthetic; Superoxides; Terpenes; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Tumor necrosis factor-alpha augments contraction and cytosolic Ca(2+) sensitivity through phospholipase A(2) in bovine tracheal smooth muscle.
Topics: Acetylcholine; Animals; Calcium; Cattle; Cytosol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fura-2; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Phospholipases A; Potassium Chloride; Quinacrine; Terpenes; Trachea; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2000 |